Related Experiment Videos
A new animal model for schizophrenia: cholinergic and serotonergic modulation
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Recent advances in the pharmacotherapy of schizophrenia.
Harvard review of psychiatry·1997
The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·1996
ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group.
Journal of clinical psychopharmacology·1996
The role of cognition in the risk--benefit and safety analysis of antipsychotic medication.
Acta psychiatrica Scandinavica. Supplementum·1996
A Nordic cohort study on cochlear implants and binaural hearing in single-sided deafness.
Acta oto-laryngologica·2026
Clinically complete spinal cord injury is not always anatomically complete.
Frontiers in neurology·2026
Early high‑frequency spinal cord stimulation modulates the ROS/p38 MAPK/NF‑κB and CXCL10/CXCR3 pathways to alleviate neuropathic pain and promote spinal cord injury repair.
International journal of molecular medicine·2026
Dynamic memory in rodent C-fibres and its impact on spinal nociceptive processing.
The Journal of physiology·2026